Sign In
Buy EXAS
$104.91
+0 (+0%)
At Close: Jun 04, 2026
Exact Sciences schedules first quarter 2021 earnings call
06:00am, Thursday, 08'th Apr 2021
MADISON, Wis., April 8, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company plans to release its first quarter 2021 financial results after the close of the U.S.
ARK Genomic Revolution Multi-Sector ETF: Poised For Continued Underperformance
07:27am, Friday, 02'nd Apr 2021
ARK Genomic Revolution Multi-Sector ETF: Poised For Continued Underperformance
Why Is Exact Sciences (EXAS) Down 8.9% Since Last Earnings Report?
12:30pm, Thursday, 18'th Mar 2021
Exact Sciences (EXAS) reported earnings 30 days ago. What's next for the stock?
New Strong Sell Stocks for March 16th
09:06am, Tuesday, 16'th Mar 2021
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
ICVT: A Tactical View On Convertible Bonds
11:07am, Friday, 12'th Mar 2021
ICVT facts and portfolio. Historical behavior. A tactical ETF rotation.
2 Genomic Stocks That Ark Funds Highlighted On Investor Day
11:46am, Wednesday, 10'th Mar 2021
Ark Funds hosted an investor webinar Tuesday, sharing ideas on several industries and portfolio components, including a discussion on some names in the genomics space. Ark Funds On Genomics: Ark Fun
Exact Sciences to participate in March investor conferences
06:00am, Monday, 22'nd Feb 2021
MADISON, Wis., Feb. 22, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following virtual conferences and invited investors to
Adding $5,000 to These 2 Top Stocks Could Make You Richer in 2021 (and Beyond)
06:17am, Sunday, 21'st Feb 2021
These two companies have exciting long-term prospects.
Why Exact Sciences Stock Sank Today
03:01pm, Wednesday, 17'th Feb 2021
The company reported disappointing Q4 results.
Exact Sciences (EXAS) Q4 Earnings, Revenues Top Estimates
10:37am, Wednesday, 17'th Feb 2021
Exact Sciences' (EXAS) legacy Screening business sees an uptick in revenues in Q4 earnings.
Exact Sciences' (EXAS) CEO Kevin Conroy on Q4 2020 Results - Earnings Call Transcript
10:45pm, Tuesday, 16'th Feb 2021
Exact Sciences' (EXAS) CEO Kevin Conroy on Q4 2020 Results - Earnings Call Transcript
Exact Sciences Falls in After-Hours Trading on Q4 Results
09:22pm, Tuesday, 16'th Feb 2021
Due to an accounting charge taken because of an acquisition, the company was deep in the red on the bottom line.
Recap: Exact Sciences Q4 Earnings
04:45pm, Tuesday, 16'th Feb 2021
Shares of Exact Sciences (NASDAQ:EXAS) fell in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 59.46% over the past year to ($0.15), which beat t
A Preview Of Exact Sciences's Earnings
10:34am, Monday, 15'th Feb 2021
Exact Sciences (NASDAQ:EXAS) announces its next round of earnings this Tuesday, February 16. Here is Benzinga's look at Exact Sciences's Q4 earnings report.
Is a Surprise Coming for Exact Sciences (EXAS) This Earnings Season?
09:53am, Friday, 12'th Feb 2021
Exact Sciences (EXAS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
